🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.3470
-0.0198 (-5.40%)
At close: Nov 19, 2026, 4:00 PM EST
0.3600
+0.0130 (3.75%)
After-hours: Nov 19, 2026, 6:41 PM EST

Neumora Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
85.65182.53142.15374.04240.94409.25
Short-Term Investments
--165.4379.94130.94-
Cash & Short-Term Investments
85.65182.53307.58453.98371.88409.25
Cash Growth
-50.06%-40.66%-32.25%22.08%-9.13%113.17%
Other Receivables
----0.920.2
Receivables
----0.920.2
Prepaid Expenses
9.098.015.26181.621.2
Restricted Cash
--1.21-0.050.13
Other Current Assets
---6.313.484.84
Total Current Assets
94.75190.54314.06478.28387.96415.6
Property, Plant & Equipment
0.230.462.926.8610.644.04
Long-Term Investments
---9.8523.51-
Long-Term Deferred Charges
----2.91.83
Other Long-Term Assets
0.070.05-1.211.237.82
Total Assets
95.05191.05316.97496.2426.23429.3

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.953.383.310.347.151.64
Accrued Expenses
18.8928.7924.5921.2611.5419.1
Current Portion of Leases
0.270.281.853.383.371.06
Other Current Liabilities
--0.130.141.641.49
Total Current Liabilities
23.1932.4529.8925.1123.723.28
Long-Term Debt
53.354.53----
Long-Term Leases
-0.19-1.855.071
Other Long-Term Liabilities
--0.020.160.630.39
Total Liabilities
76.587.1829.9127.1229.424.66

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.020.0200.01
Additional Paid-In Capital
1,3341,2881,2341,17321.4311.37
Retained Earnings
-1,315-1,184-947.22-703.43-467.51-336.61
Comprehensive Income & Other
--0.06-0.08-0.77-
Total Common Equity
18.55103.87287.06469.08-446.85-325.22
Shareholders' Equity
18.55103.87287.06469.08396.84404.64
Total Liabilities & Equity
95.05191.05316.97496.2426.23429.3

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
53.5755.011.855.238.442.05
Net Cash (Debt)
32.09127.52305.73458.6386.95407.2
Net Cash Growth
-78.81%-58.29%-33.34%18.52%-4.97%114.39%
Net Cash Per Share
0.180.781.927.0514.2218.60
Filing Date Shares Outstanding
188.69182.04161.98158.8932.6131.98
Total Common Shares Outstanding
188.69174.26161.71158.8332.6131.98
Working Capital
71.55158.09284.17453.17364.26392.33
Book Value Per Share
0.100.601.782.95-13.70-10.17
Tangible Book Value
18.55103.87287.06469.08-446.85-325.22
Tangible Book Value Per Share
0.100.601.782.95-13.70-10.17
Machinery
-0.233.193.182.942.3
Construction In Progress
---0.040.510.22
Leasehold Improvements
----0.020.26
SEC Filings: 10-K · 10-Q